Metrochem API Private Limited Metrochem API Private Limited


Find Brivaracetam manufacturers, exporters & distributors on PharmaCompass

Related ProductsRelated Products
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications


JDMFs Filed

JDMFs Filed




Listed Suppliers

Listed Suppliers

USA (Orange Book)

USA (Orange Book)







South Africa

South Africa


Uploaded Dossiers

Uploaded Dossiers


U.S. Medicaid


Annual Reports


USFDA Orange Book Patents

USFDA Exclusivities


Blog #PharmaFlow









Other Listed Suppliers



Looking for 357336-20-0 / Brivaracetam API manufacturers, exporters & distributors?

Brivaracetam manufacturers, exporters & distributors 1


PharmaCompass offers a list of Brivaracetam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Brivaracetam manufacturer or Brivaracetam supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Brivaracetam manufacturer or Brivaracetam supplier.

PharmaCompass also assists you with knowing the Brivaracetam API Price utilized in the formulation of products. Brivaracetam API Price is not always fixed or binding as the Brivaracetam Price is obtained through a variety of data sources. The Brivaracetam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name



357336-20-0, Briviact, Ucb-34714, Ucb 34714, Ucb34714, 2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide

Cas Number


Unique Ingredient Identifier (UNII)


About Brivaracetam

Brivaracetam is an orally bioavailable levetiracetam derivative, with anticonvulsant activity. Although the exact mechanism through which brivaracetam exerts its effects is not fully known, this agent targets and binds to synaptic vesicle protein 2A (SV2A) in the brain. This prevents synaptic vesicle exocytosis and the synaptic release of certain, as of yet not fully known, excitatory neurotransmitters. This may inhibit impulse conduction across synapses, decrease neuronal (hyper-)excitability, and may modulate epileptogenesis. SV2A, a membrane glycoprotein present in neuronal synaptic vesicles, plays a key role in action potential-induced neurotransmitter release in the brain.

Brivaracetam Manufacturers

A Brivaracetam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brivaracetam, including repackagers and relabelers. The FDA regulates Brivaracetam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brivaracetam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Brivaracetam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Brivaracetam Suppliers

A Brivaracetam supplier is an individual or a company that provides Brivaracetam active pharmaceutical ingredient (API) or Brivaracetam finished formulations upon request. The Brivaracetam suppliers may include Brivaracetam API manufacturers, exporters, distributors and traders.

click here to find a list of Brivaracetam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Brivaracetam USDMF

A Brivaracetam DMF (Drug Master File) is a document detailing the whole manufacturing process of Brivaracetam active pharmaceutical ingredient (API) in detail. Different forms of Brivaracetam DMFs exist exist since differing nations have different regulations, such as Brivaracetam USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Brivaracetam DMF submitted to regulatory agencies in the US is known as a USDMF. Brivaracetam USDMF includes data on Brivaracetam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Brivaracetam USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Brivaracetam suppliers with USDMF on PharmaCompass.

Brivaracetam KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Brivaracetam Drug Master File in Korea (Brivaracetam KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Brivaracetam. The MFDS reviews the Brivaracetam KDMF as part of the drug registration process and uses the information provided in the Brivaracetam KDMF to evaluate the safety and efficacy of the drug.

After submitting a Brivaracetam KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Brivaracetam API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Brivaracetam suppliers with KDMF on PharmaCompass.

Brivaracetam WC

A Brivaracetam written confirmation (Brivaracetam WC) is an official document issued by a regulatory agency to a Brivaracetam manufacturer, verifying that the manufacturing facility of a Brivaracetam active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Brivaracetam APIs or Brivaracetam finished pharmaceutical products to another nation, regulatory agencies frequently require a Brivaracetam WC (written confirmation) as part of the regulatory process.

click here to find a list of Brivaracetam suppliers with Written Confirmation (WC) on PharmaCompass.

Brivaracetam NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Brivaracetam as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Brivaracetam API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Brivaracetam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Brivaracetam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Brivaracetam NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Brivaracetam suppliers with NDC on PharmaCompass.

Brivaracetam GMP

Brivaracetam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Brivaracetam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Brivaracetam GMP manufacturer or Brivaracetam GMP API supplier for your needs.

Brivaracetam CoA

A Brivaracetam CoA (Certificate of Analysis) is a formal document that attests to Brivaracetam's compliance with Brivaracetam specifications and serves as a tool for batch-level quality control.

Brivaracetam CoA mostly includes findings from lab analyses of a specific batch. For each Brivaracetam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Brivaracetam may be tested according to a variety of international standards, such as European Pharmacopoeia (Brivaracetam EP), Brivaracetam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Brivaracetam USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry